Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  Issue: April 2015  |  April 1, 2015

Less is more. The new mantra for medicine.


ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Simon M. Helfgott, MD

Simon M. Helfgott, MD, is associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School in Boston.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Brill S. America’s Bitter Pill. Money, Politics, Backroom Deals and the Fight to Fix Our Broken Healthcare System. Random House. New York 2015.
  2. Auletta K. Blood, simpler: One woman’s drive to revolutionize medical testing. The New Yorker. 2014 Dec 15. http://www.newyorker.com/magazine/2014/12/15/blood-simpler.
  3. Theranos. https://www.theranos.com/test-menu?ref=our_solution.
  4. Burton TM, Gormley B. FDA signals easier rule on genetic tests. The Wall Street Journal. 2015 Feb 21. http://www.wsj.com/articles/fda-signals-easier-rule-on-genetic-tests-1424468927.
  5. Rosenthal E. In need of a new hip, but priced out of the U.S. The New York Times. 2013 Aug 3. http://www.nytimes.com/2013/08/04/health/for-medical-tourists-simple-math.html?_r=0.
  6. Medical Tourism Statistics & Facts. Patients Beyond Borders. 2014 Jul 6. http://www.patientsbeyondborders.com/medical-tourism-statistics-facts.
  7. Walmart, Lowe’s enter bundled pay deal with four health systems. The Advisory Board Co. 2013 Oct 9. http://www.advisory.com/Daily-Briefing/2013/10/09/Walmart-Lowes-enter-bundled-pay-deal-with-four-health-systems.
  8. Ranard BL, Yoonhee PH, Meisel ZF, et al. Crowdsourcing—harnessing the masses to advance health and medicine, a systematic review. J Gen Intern Med. 2014 Jan;29(1):187–203.
  9. Arnold C. Can the crowd solve medical mysteries? NOVA Next. 2014 Aug 20. http://www.pbs.org/wgbh/nova/next/body/crowdsourcing-medical-diagnoses.
  10. Sanders L. Think like a doctor: Swept off her feet solved. The New York Times. 2015 Feb12. http://well.blogs.nytimes.com/2015/02/12/think-like-a-doctor-swept-off-her-feet-solved.
  11. Jena AB, Prasad V, Goldman DP, et al. Mortality and treatment patterns among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings. JAMA Intern Med. 2015 Feb 1;175(2):237–244.

Correction

An error was introduced in the editing process to Figure 3 GiACTA Study Schema, in “Giant Cell Arteritis” (The Rheumatologist, March 2015). Tocilizumab should have been represented by the acronym TCZ, and there was a mistake in the dosing schedule. To see the correct version of the figure, visit http://www.the-rheumatologist.org/details/article/7577501/Giant_Cell_Arteritis_Challenging_to_Diagnose_Manage.html. We regret the error.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:costsHealth InsuranceHelfgottMedicationprescription drugrheumatologysurgical procedure

Related Articles

    Technological Advances Linked to Medical Misadventures

    April 15, 2016

    For keen students of American politics, the unending intrigue of the 2016 presidential race has been riveting. With an assemblage of aspiring candidates that, at its start, included a bevy of U.S. senators and former governors, a media-savvy real estate mogul, a renowned Hopkins neurosurgeon and an ophthalmologist, political junkies among us have feasted on…

    Crowdsourcing: The Modern Consult Equivalent

    October 13, 2015

    Two of the great traditions of medicine are the curbside and party consults. In the former, participating physicians informally discuss an especially difficult diagnostic problem. During the latter, a patient will approach the doctor to ask about some possible medical problem and what they should do about it. The advent of the Internet has brought…

    Theranos Lab May Pose Jeopardy to Patient Health

    February 1, 2016

    (Reuters)—Deficient practices at a lab operated by blood-testing startup Theranos pose “immediate jeopardy to patient health and safety,” the U.S. government’s Centers for Medicare & Medicaid Services said in a letter to the company released on Wednesday. Theranos, founded and led by Elizabeth Holmes, has been in the spotlight after reports in the Wall Street…

    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences